|
2025-10-03 |
2025-10-02 |
V
Vente
|
EVP Operations
Dirigeant
|
76 121
+19.4%
287,48
2 606 307 $US
|
76 121
+19.4%
|
287,48
|
2 606 307 $US
|
|
|
2025-08-26 |
2025-08-22 |
V
Vente
|
EVP Operations
Dirigeant
|
60 063
-39.2%
304,58
4 075 820 $US
|
60 063
-39.2%
|
304,58
|
4 075 820 $US
|
|
|
2025-08-22 |
2025-08-22 |
PrS
Vente proposée
|
Officer
Dirigeant
|
74 884
52,22
4 500 875 $US
|
74 884
|
52,22
|
4 500 875 $US
|
|
|
2025-07-25 |
2025-07-10 |
A
Achat
|
Chief Commercial Officer
Dirigeant
|
16 366
+inf%
0,59
9 640 $US
|
16 366
+inf%
|
0,59
|
9 640 $US
|
|
|
2025-07-10 |
2025-07-08 |
V
Vente
|
EVP Operations
Dirigeant
|
200 000
-8.0%
0,58
115 800 $US
|
200 000
-8.0%
|
0,58
|
115 800 $US
|
|
|
2025-07-08 |
2025-07-08 |
PrS
Vente proposée
|
Officer
Dirigeant
|
500 000
0,61
303 000 $US
|
500 000
|
0,61
|
303 000 $US
|
|
|
2024-10-28 |
2024-10-24 |
V
Vente
|
SVP of Operations
Dirigeant
|
333 932
-100.0%
0,51
170 305 $US
|
333 932
-100.0%
|
0,51
|
170 305 $US
|
|
|
2024-10-28 |
2024-10-23 |
V
Vente
|
SVP of Operations
Dirigeant
|
800 000
-70.6%
0,49
392 000 $US
|
800 000
-70.6%
|
0,49
|
392 000 $US
|
|
|
2024-10-23 |
2024-10-23 |
PrS
Vente proposée
|
Officer
Dirigeant
|
1 133 932
0,60
680 359 $US
|
1 133 932
|
0,60
|
680 359 $US
|
|
|
2016-03-21 |
2016-03-18 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
258 090
-3.3%
0,34
88 267 $US
|
258 090
-3.3%
|
0,34
|
88 267 $US
|
|
|
2016-03-21 |
2016-03-17 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
312 430
-3.8%
0,35
107 788 $US
|
312 430
-3.8%
|
0,35
|
107 788 $US
|
|
|
2016-02-24 |
2016-02-24 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
100 456
-1.2%
0,31
31 141 $US
|
100 456
-1.2%
|
0,31
|
31 141 $US
|
|
|
2016-02-24 |
2016-02-22 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
100 000
-1.2%
0,32
32 090 $US
|
100 000
-1.2%
|
0,32
|
32 090 $US
|
|
|
2016-02-18 |
2016-02-17 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
50 000
-0.6%
0,31
15 580 $US
|
50 000
-0.6%
|
0,31
|
15 580 $US
|
|
|
2016-02-18 |
2016-02-05 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
24 400
-0.3%
0,33
8 052 $US
|
24 400
-0.3%
|
0,33
|
8 052 $US
|
|
|
2016-02-18 |
2016-02-04 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
349 660
-4.0%
0,32
111 891 $US
|
349 660
-4.0%
|
0,32
|
111 891 $US
|
|
|
2016-02-18 |
2016-02-03 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
45 518
-0.5%
0,33
15 021 $US
|
45 518
-0.5%
|
0,33
|
15 021 $US
|
|
|
2016-02-18 |
2016-02-02 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
13 000
-0.1%
0,33
4 290 $US
|
13 000
-0.1%
|
0,33
|
4 290 $US
|
|
|
2016-02-18 |
2016-02-01 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
312 300
-3.4%
0,34
106 182 $US
|
312 300
-3.4%
|
0,34
|
106 182 $US
|
|
|
2016-02-18 |
2016-01-29 |
V
Vente
|
TREPPEL JERRY
former Chairman
|
115 000
-1.3%
0,35
40 250 $US
|
115 000
-1.3%
|
0,35
|
40 250 $US
|
|
|
2015-11-18 |
2015-11-18 |
V
Vente
|
TREPPEL JERRY
Chairman of Board
Administrateur exécutif
|
25 000
-0.3%
0,31
7 625 $US
|
25 000
-0.3%
|
0,31
|
7 625 $US
|
|
|
2015-11-18 |
2015-11-17 |
V
Vente
|
TREPPEL JERRY
Chairman of Board
Administrateur exécutif
|
25 000
-0.3%
0,30
7 502 $US
|
25 000
-0.3%
|
0,30
|
7 502 $US
|
|
|
2015-11-18 |
2015-11-16 |
V
Vente
|
TREPPEL JERRY
Chairman of Board
Administrateur exécutif
|
50 000
-0.5%
0,30
15 125 $US
|
50 000
-0.5%
|
0,30
|
15 125 $US
|
|
|
2015-11-18 |
2015-11-13 |
V
Vente
|
TREPPEL JERRY
Chairman of Board
Administrateur exécutif
|
50 000
-0.5%
0,30
15 000 $US
|
50 000
-0.5%
|
0,30
|
15 000 $US
|
|
|
2015-04-28 |
2015-04-27 |
V
Vente
|
Plassche Douglas
Executive VP of Operations
Dirigeant
|
85 530
-53.9%
0,24
20 168 $US
|
85 530
-53.9%
|
0,24
|
20 168 $US
|
|
|
2014-09-29 |
2014-09-26 |
A
Achat
|
Hakim Nasrat A
CEO & President
Administrateur exécutif
|
265 500
+10.9%
0,31
82 385 $US
|
265 500
+10.9%
|
0,31
|
82 385 $US
|
|
|
2014-09-29 |
2014-09-25 |
A
Achat
|
Hakim Nasrat A
CEO & President
Administrateur exécutif
|
434 500
+21.7%
0,31
133 956 $US
|
434 500
+21.7%
|
0,31
|
133 956 $US
|
|
|
2014-05-13 |
2014-05-09 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
329 437
-5.6%
0,38
125 944 $US
|
329 437
-5.6%
|
0,38
|
125 944 $US
|
|
|
2014-04-04 |
2014-04-02 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
147 664
-2.5%
0,41
60 542 $US
|
147 664
-2.5%
|
0,41
|
60 542 $US
|
|
|
2014-03-31 |
2014-03-27 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
190 172
-3.1%
0,43
81 165 $US
|
190 172
-3.1%
|
0,43
|
81 165 $US
|
|
|
2014-03-17 |
2014-03-11 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
239 367
-1.2%
0,60
144 003 $US
|
239 367
-1.2%
|
0,60
|
144 003 $US
|
|
|
2014-03-17 |
2014-03-11 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
239 367
-0.4%
0,60
144 003 $US
|
239 367
-0.4%
|
0,60
|
144 003 $US
|
|
|
2014-03-17 |
2014-03-11 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
239 367
-1.6%
0,60
144 003 $US
|
239 367
-1.6%
|
0,60
|
144 003 $US
|
|
|
2014-03-17 |
2014-03-11 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
239 367
-0.4%
0,60
144 003 $US
|
239 367
-0.4%
|
0,60
|
144 003 $US
|
|
|
2014-03-10 |
2014-03-07 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
1 051 450
-6.6%
0,68
714 986 $US
|
1 051 450
-6.6%
|
0,68
|
714 986 $US
|
|
|
2014-03-10 |
2014-03-07 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
1 051 450
-4.9%
0,68
714 986 $US
|
1 051 450
-4.9%
|
0,68
|
714 986 $US
|
|
|
2014-03-10 |
2014-03-07 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
1 051 450
-1.5%
0,68
714 986 $US
|
1 051 450
-1.5%
|
0,68
|
714 986 $US
|
|
|
2014-03-10 |
2014-03-07 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
1 051 450
-1.5%
0,68
714 986 $US
|
1 051 450
-1.5%
|
0,68
|
714 986 $US
|
|
|
2014-03-10 |
2014-03-06 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
773 050
-4.8%
0,90
692 344 $US
|
773 050
-4.8%
|
0,90
|
692 344 $US
|
|
|
2014-03-10 |
2014-03-06 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
773 050
-3.6%
0,90
692 344 $US
|
773 050
-3.6%
|
0,90
|
692 344 $US
|
|
|
2014-03-10 |
2014-03-06 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
773 050
-1.1%
0,90
692 344 $US
|
773 050
-1.1%
|
0,90
|
692 344 $US
|
|
|
2014-03-10 |
2014-03-06 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
773 050
-1.1%
0,90
692 344 $US
|
773 050
-1.1%
|
0,90
|
692 344 $US
|
|
|
2014-01-17 |
2014-01-13 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
805 583
-1.1%
0,18
147 422 $US
|
805 583
-1.1%
|
0,18
|
147 422 $US
|
|
|
2014-01-17 |
2014-01-13 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
805 583
-5.0%
0,18
147 422 $US
|
805 583
-5.0%
|
0,18
|
147 422 $US
|
|
|
2014-01-17 |
2014-01-13 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
805 583
-3.7%
0,18
147 422 $US
|
805 583
-3.7%
|
0,18
|
147 422 $US
|
|
|
2014-01-17 |
2014-01-13 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
805 538
-1.1%
0,18
147 413 $US
|
805 538
-1.1%
|
0,18
|
147 413 $US
|
|
|
2013-12-16 |
2013-12-05 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
275 000
-0.4%
0,13
34 512 $US
|
275 000
-0.4%
|
0,13
|
34 512 $US
|
|
|
2013-12-13 |
2013-12-05 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
275 000
-0.4%
0,13
34 512 $US
|
275 000
-0.4%
|
0,13
|
34 512 $US
|
|
|
2013-12-13 |
2013-12-05 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
275 000
-1.7%
0,13
34 512 $US
|
275 000
-1.7%
|
0,13
|
34 512 $US
|
|
|
2013-12-13 |
2013-12-05 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
275 000
-1.3%
0,13
34 512 $US
|
275 000
-1.3%
|
0,13
|
34 512 $US
|
|
|
2013-12-04 |
2013-12-02 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
100 000
-0.1%
0,13
12 520 $US
|
100 000
-0.1%
|
0,13
|
12 520 $US
|
|
|
2013-12-04 |
2013-12-02 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
100 000
-0.1%
0,13
12 520 $US
|
100 000
-0.1%
|
0,13
|
12 520 $US
|
|
|
2013-12-04 |
2013-12-02 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
100 000
-0.5%
0,13
12 520 $US
|
100 000
-0.5%
|
0,13
|
12 520 $US
|
|
|
2013-11-29 |
2013-11-27 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
25 000
-0.0%
0,12
3 030 $US
|
25 000
-0.0%
|
0,12
|
3 030 $US
|
|
|
2013-11-29 |
2013-11-27 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
25 000
-0.1%
0,12
3 030 $US
|
25 000
-0.1%
|
0,12
|
3 030 $US
|
|
|
2013-11-29 |
2013-11-27 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
25 000
-0.2%
0,12
3 030 $US
|
25 000
-0.2%
|
0,12
|
3 030 $US
|
|
|
2013-11-29 |
2013-11-27 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
25 000
-0.0%
0,12
3 030 $US
|
25 000
-0.0%
|
0,12
|
3 030 $US
|
|
|
2013-12-16 |
2013-11-26 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
23 626
-0.0%
0,12
2 793 $US
|
23 626
-0.0%
|
0,12
|
2 793 $US
|
|
|
2013-12-13 |
2013-11-26 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
23 626
-0.0%
0,12
2 793 $US
|
23 626
-0.0%
|
0,12
|
2 793 $US
|
|
|
2013-12-13 |
2013-11-26 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
23 626
-0.2%
0,12
2 793 $US
|
23 626
-0.2%
|
0,12
|
2 793 $US
|
|
|
2013-12-13 |
2013-11-26 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
23 626
-0.1%
0,12
2 793 $US
|
23 626
-0.1%
|
0,12
|
2 793 $US
|
|
|
2013-11-29 |
2013-11-26 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
357 000
-0.5%
0,12
43 126 $US
|
357 000
-0.5%
|
0,12
|
43 126 $US
|
|
|
2013-11-29 |
2013-11-26 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
357 000
-1.6%
0,12
43 126 $US
|
357 000
-1.6%
|
0,12
|
43 126 $US
|
|
|
2013-11-29 |
2013-11-26 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
357 000
-2.2%
0,12
43 126 $US
|
357 000
-2.2%
|
0,12
|
43 126 $US
|
|
|
2013-11-29 |
2013-11-26 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
357 000
-0.5%
0,12
43 126 $US
|
357 000
-0.5%
|
0,12
|
43 126 $US
|
|
|
2013-11-19 |
2013-11-19 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
21 000
-0.0%
0,12
2 457 $US
|
21 000
-0.0%
|
0,12
|
2 457 $US
|
|
|
2013-11-19 |
2013-11-19 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
21 000
-0.1%
0,12
2 499 $US
|
21 000
-0.1%
|
0,12
|
2 499 $US
|
|
|
2013-11-19 |
2013-11-19 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
21 000
-0.1%
0,12
2 457 $US
|
21 000
-0.1%
|
0,12
|
2 457 $US
|
|
|
2013-11-19 |
2013-11-19 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
21 000
-0.0%
0,12
2 457 $US
|
21 000
-0.0%
|
0,12
|
2 457 $US
|
|
|
2013-11-19 |
2013-11-18 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
1 170 000
-1.6%
0,12
137 475 $US
|
1 170 000
-1.6%
|
0,12
|
137 475 $US
|
|
|
2013-11-19 |
2013-11-18 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
1 170 000
-6.9%
0,12
137 475 $US
|
1 170 000
-6.9%
|
0,12
|
137 475 $US
|
|
|
2013-11-19 |
2013-11-18 |
V
Vente
|
NIGALAYE ASHOK G
Chief Scientific Officer
Administrateur exécutif
Actionnaire important
|
1 170 000
-5.1%
0,12
137 475 $US
|
1 170 000
-5.1%
|
0,12
|
137 475 $US
|
|
|
2013-11-19 |
2013-11-18 |
V
Vente
|
EPIC PHARMA LLC
Actionnaire important
|
1 170 000
-1.6%
0,12
137 475 $US
|
1 170 000
-1.6%
|
0,12
|
137 475 $US
|
|
|
2013-11-19 |
2013-11-15 |
V
Vente
|
EPIC INVESTMENTS, LLC
Actionnaire important
|
318 050
-0.4%
0,12
37 307 $US
|
318 050
-0.4%
|
0,12
|
37 307 $US
|
|
|
2013-11-19 |
2013-11-15 |
V
Vente
|
NARINE JEENARINE
Administrateur non-exécutif
Actionnaire important
|
318 050
-1.9%
0,12
37 307 $US
|
318 050
-1.9%
|
0,12
|
37 307 $US
|
|